Health Innovation Summit by Corporate Venturing Professionals Roundtable III

Mission objective of the July 2017 Summit:Developing business collaborations among participating delegates among healthcare professionals, investors, business operators of different geographies by focusing on disruptive innovations lead by venture portfolios

What is the focus of this event?• The conference is centered around “Health Innovation” with a special interest on finding

solutions for issues relating to aging societies around the globe.

Who attends? Three types of delegates will attend the SummitvHealthcare professionals and researchers vInvestors (VCs, Incubators, Accelerators & Growth Capital Funds)vBusiness operators of all sizes: o large established companies (people engaged in business planning, CVCs and M&A) o privately owned mid-size companies (with distinctive manufactures & services)o venture capital portfolio companies (from North America, Japan, Asia, Europe)

Key messages sought from speakers: • Healthcare professionals and researchers: What issues are we facing in healthcare today & tomorrow• Investors: What disruptive innovations we are betting on, and how we make them successful w/examples• Business operators: New business strategies of today & tomorrow in a context of open innovation• Venture portfolios: “This is who we are & what we do” through Rapid-fire Presentations

Topics of interest: Wide ranging ideas on Health Innovation including digital health, IT, services, medical instruments, medical robotics, new materials, biotechnology, health science as well as new drug discoveries.

What is so unique about this Summit?• We use web-conferencing technology extensively at this conference• Speakers are invited from from North America, Japan, Asia and Europe to a single forum via the web-conference• It is no longer necessary to travel long distance to attend/speak at the conference• We also host physical conference venues in Tokyo, Silicon Valley and Munich as the majority of delegates

are still expected to meet-up in person as there is nothing to substitute face-to-face networking

●Main Venue: Nihonbashi Life Science Hub in Tokyo (Muromachi Chiba Bank Mitsui Building, 8F)Date: Tuesday, 7/11Time: 8:00 - 19:10 (Reception from 19:10 – 20:30) Rapid-fire presentation: 15:10 - 16:00Capacity: 60 to 80 people including speakers

●Satellite Venue in Silicon Valley hosted by TMI Associates (San Mateo)Date: Monday, 7/10Time: Panel Sessions: 16:00 – 19:30 WST (Tokyo-SV are connected via Web conferencing)Rapid-fire presentations: 19:30 to 21:00 WST After 21:00 all local participation to this conference shall be switched to video streaming & a chat room. Capacity:25 to 35 people including speakers

●Satellite Venue in Munich hosted by ARQIS RechtsanwälteDate: Monday, 7/11Time: Panel Sessions: 9:00 – 11:10 (Munich time) (Tokyo-Munich are connected via Web conferencing)Rapid-fire presentations: 11:10 – 12:00Networking Lunch: 12:00 -13:00Capacity:15 to 25 people including speakers

●Other regions of the world (speaker participation via Web conference) Asian cities (China, Singapore, etc.)The number of speakers and presenters: 15 to 20 people

Organizer： Astoria Consulting GroupContact Info.: hm@astoriacg.com Hal Morimoto

Co-organizers：Life Science Innovation Network Japan (LINK-J)National Graduate Institute of Policy Studies (GRIPS)

1

July2017

JPNTime Program WST

(SV)

8:15-11:30

N.A. SessionsKeynote x２、Panel x4

16:15-19:30

11:30-13:00

SV: Reception & Rapid-fire PresentationsTYO: Networking Lunch

19:30-21:00

13:00-14:05

Japan SessionKeynote x1, Panel x 1

14:05-15:10

Asia SessionKeynote x1, Panel x 1

15:10-16:00

TYO: Networking Break &Rapid-fire Presentations

MunichTime

16:00-19:10

Europe SessionsKeynote x1, Panel x 2Closing Note x 1 (TYO)

9:00-11:10

19:10-20:30

Munich: Networking Lunch & Rapid-fire Presentations TYO: Reception

11:10-13:00

※※Primarylanguageattheconference:English

Health Innovation Summit for Corporate Venturing Professionals Roundtable III

Confirmed Speakers (Preliminary)

Japan Session

Tokyo: Keynote AddressKiyoshi Kurokawa, MD, Hon. Prof., National Graduate School of Policy Institute Chairman, Health and Global Policy Institute

Tokyo: Japan Session SpeakerHiroaki Yoshida, MD, Vice ChairmanHealth and Global Policy Institute

Tokyo: North America Panel – ModeratorJohn Y. SasakiAttorney-at-Law, JSV Foreign Law Office

Tokyo: Japan Panel – Speaker James Riney500 Startups

近⽇3名追加予定3 more speakers to be announced soon.

Asia Session

Asia Panel – Speaker Ruby Lu, PartnerH Capital

Asia Panel – SpeakerMasahiko Honma, Managing Partner Incubate Fund

Asia Panel ModeratorGerald J. Hane, PhDPresident & CEOAEGLE HEALTH

近⽇2名追加予定。ジャパン・アジアセッションの後、最⼤6社のVC出資先企業によるラピッドファイア・プレゼンを予定2 more speakers to be announced soon. There will be up to 6 venture portfolio companies presented after the Japan/Asia sessions.

North America Sessions

SV: North Americal Panel – SpeakerFumiaki Ikeno, MD, Chief Medical Officer, Medventure PartnersProgram Dir., Japan Biodesign at Stanford

SV: North Americal Panel – Speaker Carrie Earle Allen, Executive Director Captains of Innovation Program, CIC

SV: North Americal Panel – Speaker Peter Moran, General PartnerDCM Ventures

SV: North Americal Panel – Speaker Gen Isayama1, CEOWiL

SV: North Americal Panel Masashi Kiyomine, Investment DirectorMitsui Global Investment

SV: North America PanelYasuo Miyazawa, PresidentNitto Innovations

近⽇８名追加予定。北⽶セッションの後、最⼤９社のVC出資先企業によるラピッドファイア・プレゼンを予定Up to 8 more speakers to be announced soon. There will be up to ９ venture portfolio companies presented after the North America Session.

Europe Sessions

Europe Panel – SpeakerAnne M. Glover, CEOAmadeus Capital Partners

Europe Panel – SpeakerTetsuyuki Maruyama, PhD, CSODementia Discovery Fund

Europe Panel – Speaker Thom Rasche, PartnerEarlybird VC Management GmbH

近⽇７名追加予定。欧州セッションの後、最⼤6社のVC出資先企業によるラピッドファイア・プレゼンを予定Up to 7 more speakers to be announced soon. There will be up to 6 venture portfolio companies presented after the Europe session.

2

July2017

3

Innovation Occurs Where The Three Key Components Meet

The Health Innovation Summit is Where The Three Circles of “Talent, Fund and Technology” Meet

• Talent : Healthcare professionals, researchers and business operators of all sizes (from large-established to venture portfolios)

• Fund : VCs and Growth Capital Funds、Incubators• Technology: Disruptive innovations being developed (and applicable in

healthcare field)

Talent

TechnologyFund

Innovation

Health Innovation Summit for Corporate Venturing Professionals Roundtable III

July2017

Type of Business Tokyo NA (SV) Asia,Europe Total

Corporates (CV/CVCs/M&A) 20 5 5 30

VCs 5 10 10 25

Venture Portfolios 5 10 5 15

Growth Stage Cos. 10 -- -- 10

Organizers 15 3 2 20

Total 60 25 15 100

Who attends? Target Number:

Time Time

4

Health Innovation Summit for Corporate Venturing Professionals Roundtable III

July2017

Tokyo Working Program-I (Silicon Valley-Tokyo) SV

7:30 -8:00 Registration (Coffee/Tea) 15:30-

16:00

8:00-8:15 Opening Note by: (North America) 16:00-

16:15

8:15-9:00

1. North American PanelModerator: Moderator in Silicon ValleyPanelist: VC from BostonPanelist: Incubator from BostonPanelist: VC/Incubator from Toronto

16:15-17:00

9:00-9:45

2. North American PanelModerator: CVC to moderatePanelist: VC from SVPanelist: VC from TorontoPanelist: VC from SV

17:00-17:45

9:45-10:00 Networking Break 17:45-

18:00

10:00-10:15 Keynote Address by: (North America) 18:00-

18:15

10:15-11:00

3. Best Practices in Open InnovationModerator: Moderator in TokyoPanelist: CVC from Silicon Valley (JPN)Panelist: CVC from Silicon Valley (JPN)Panelist: CVC from Silicon Valley

18:15-19:00

11:00-11:45

4. North American PanelModerator: Moderator in TokyoPanelist: VC from SVPanelist: VC from BC, CanadaPanelist: Incubator from San Diego

19:00-19:45

11:45-13:00

Tokyo: LunchSV: Reception

(Up to 9 rapid fire presentations from North America)

19:45-20:00

Tokyo Working Program-II (Tokyo-Asia) HK*

13:00-13:15 Keynote Address by: TBD (Japan) 12:00-

12:15

13:15-14:05

5. Japan PanelModerator: Healthcare Professional (JPN)Panelist: VC from JapanPanelist: Incubator/VC from JapanPanelist: VC from JapanPanelist: CVC from Japan

12:15-13:05

14:05-14:20 A short speech by: TBD 13:05-

13:20

14:20-15:10

6. Asia PanelModerator: Healthcare Professional (Asia)Panelist: VC from Beijing/HKPanelist: VC from SingaporePanelist: VC from AsiaPanelist: CVC from Asia

13:20-14:10

15:10-16:00 Networking Break

(Up to 6 rapid fire presentations from Japan and Asia)

14:10-15:00

*Note: Currently no conference venue in Asian cities planned; speakers from Asian cities will appear on web-conference.

Tokyo Working Program-III (Tokyo-Munich) MUC

16:00-16:15 Opening Speech by: TBD (Europe) 9:00-

9:15

16:15-17:05

7. Europe PanelModerator: Healthcare ProfessionalPanelist: VC from GermanyPanelist: VC from GermanyPanelist: CVC from EuropePanelist: VC from Eurpoe

9:15-10:05

17:05-18:55

8. Europe PanelModerator: Healthcare ProfessionalPanelist: VC from LondonPanelist: VC from LondonPanelist: VC from FrancePanelist: CVC from Europe

10:05-10:55

18:55-19:10 Closing Note by : TBD 10:55-

11:10

19:10-20:30

Tokyo: Reception

(Up to 6 rapid fire presentations from Europe)

11:10-12:00

Europe: Networking Lunch

12:00-13:00

PRELIMINARY PROGRAM

5

Health Innovation Summit for Corporate Venturing Professionals Roundtable III

July2017

Partial list of expected delegates in Japan*

The following 28 large-established firms are expected to attend the next Summit:

Aderance Co.Ajinomoto Co.Astellas PharmaBayer YakuhinChugai PharmaceuticalDaiichi PharmaceuticalDenso CorporationDevelopment Bank of JapanEli Lilly Japan KKFuji XeroxFujifilmHitachi Corporation Healthcare Business UnitIndustrial Growth Platform, Inc. Japanese Organization for Medical Device Development, Inc.JTKYOCERA Communication Systems Co.Mazda Motor CorporationMiraca Holdings

NEC Capital Solutions

Nissan MotorOlympus CorporationOmron Electronic Components LLCPfizer Japan Inc.Sanofi KK

Sekisui Chemical Co., Ltd.

Sompo HoldingsTakeda PharmaceuticalYamaha Motor Co., Ltd.• Delegate Registration to Open from May 30.

Official Delegate List will be available in June.

Partial list of expected delegates in North America & Europe*

The following 11 corporate venturing units of large established firms are expected to attend the next Summit:

AGC America, Inc.Astellas Venture Management

Hitachi Solutions America, Ltd.

IHI AmericaMazda North American Operations

McKesson

NEC America

Nitto Innovations, Inc.

Sompo Digital Lab

Toray Industries (America), Inc.Yamaha Motor Ventures & Laboratory Silicon Valley• Delegate Registration to Open from May 30.

Official Delegate List will be available in June.

PRELIMINARY DELEGATE INFORMATION